首页 › 基金 › XXEC, Inc. › HTFL
XXEC, Inc. 对 HTFL 的持仓历史
HEARTFLOW INC · 医疗保健
XXEC, Inc. 在 Q3 2026 的 13F 申报中披露持有 HTFL(HEARTFLOW INC)60,040 股,市值约 US$3.0M,约占其申报组合的 4.36%,在其申报持仓中市值排名第 9 位。 XXEC, Inc. 最近 5 个申报季度中有 5 个季度披露了 HTFL 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
XXEC, Inc. 对 HTFL 的持仓演变
XXEC, Inc. 于 Q3 2025 首次披露 HTFL 持仓:29,832 股(约 US$1.0M)。 该持仓在 Q2 2026 达到峰值 599,194 股,市值约 US$18.4M。 在 5 次申报中,XXEC, Inc. 3 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 60,040 股、市值约 US$3.0M,环比减持 -539,154 股。。 持仓曾出现大幅变动:Q1 2026 增持约 565% (随后一个季度股价上涨 21%)、Q2 2026 增持约 115% (随后一个季度股价上涨 70%)、Q3 2026 减持约 90% (随后一个季度股价下跌 3%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 29.83K | $1.00M | 新进 |
| Q4 2025 | 41.92K | $1.22M | 增持 |
| Q1 2026 | 278.68K | $8.13M | 增持 |
| Q2 2026 | 599.19K | $18.36M | 增持 |
| Q3 2026 | 60.04K | $2.99M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HTFL 与 13F 数据
HTFL(HEARTFLOW INC)属于医疗保健行业。我们追踪的基金中还有 94 只申报持有 HTFL,申报仓位最大的包括:Bain Capital Life Sciences Investors, LLC (US$247.9M), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (US$49.7M), NEXT CENTURY GROWTH INVESTORS LLC (US$29.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HTFL 的基金
- Bain Capital Life Sciences Investors, LLC 8.45M 股 · $247.87M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 1.69M 股 · $49.72M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 590.75K 股 · $29.39M · Q3 2026
- 12 West Capital Management LP 902.50K 股 · $26.48M · Q2 2026
- NZS Capital, LLC 656.01K 股 · $19.25M · Q2 2026
- Catalio Capital Management, LP 583.05K 股 · $17.11M · Q2 2026
- Rock Springs Capital Management LP 573.50K 股 · $16.83M · Q2 2026
- Lisanti Capital Growth, LLC 155.29K 股 · $7.73M · Q3 2026
- BROWN CAPITAL MANAGEMENT LLC 101.19K 股 · $5.03M · Q3 2026
- BCWM, LLC 89.96K 股 · $4.48M · Q3 2026
- INTREPID FAMILY OFFICE LLC 110.00K 股 · $3.23M · Q2 2026
- TFC Financial Management, Inc. 55.60K 股 · $2.77M · Q3 2026
更多关于 XXEC, Inc.
常见问题
How long has XXEC, Inc. held HTFL?
XXEC, Inc. has disclosed HTFL holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is XXEC, Inc.'s current position in HTFL?
As of Q3 2026, XXEC, Inc. holds 60.04K shares of HTFL (HEARTFLOW INC), valued at $2.99M, representing 4.36% of its reported portfolio and ranking #9.
Has XXEC, Inc. been buying or selling HTFL?
In the latest 13F filing (Q3 2026), XXEC, Inc. reduced its position in HTFL. The position peaked in Q2 2026 at 599.19K shares.
Which other funds hold HTFL?
Other major institutional holders of HTFL include Bain Capital Life Sciences Investors, LLC, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, NEXT CENTURY GROWTH INVESTORS LLC, among 94 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.